NewsOf ‘miracles’ and money: Why hemophilia drugs are so expensiveAuthor:Jenny GoldPublish date: March 9, 2018The U.S. hemophilia drug market, which serves about 20,000 patients, is worth $4.6 billion a year.Read More
NewsSickle cell patients suffer discrimination, poor care – and shorter livesAuthor:Jenny GoldPublish date: November 6, 2017Sickle cell disease is “a microcosm of how issues of race, ethnicity and identity come into conflict with issues of health care.”Read More
NewsMedicare yet to save money through ACO modelAuthor:Jenny GoldPublish date: September 14, 2015A high-profile Medicare experiment pushing doctors and hospitals to join together to operate more efficiently has yet to save the government money, wi...Read More
